Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma

被引：0
|
作者：
Lan Mu
Ke Ding
Ranran Tu
Wei Yang
机构：
[1] Central South University,Department of Thyroid Surgery, The Second Xiangya Hospital
[2] Central South University,Department of Urology, Xiangya Hospital
[3] Central South University,Department of Neurology, The Second Xiangya Hospital
[4] Central South University,Department of Respiratory Medicine, National Key Clinical Specialty, Xiangya Hospital
来源：
Journal of Translational Medicine | / 19卷
关键词：
Lung adenocarcinoma; Immune infiltration; LncRNA; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Identification of heritable rare variants associated with early-stage lung adenocarcinoma risk
    Fu, Rui
    Zhang, Jia-Tao
    Chen, Rong-Rong
    Li, Hong
    Tai, Zai-Xian
    Lin, Hao-Xiang
    Su, Jian
    Chu, Xiang-Peng
    Zhang, Chao
    Qiu, Zhen-Bin
    Chen, Zi-Hao
    Tang, Wen-Fang
    Dong, Song
    Yang, Xue-Ning
    Zhang, Guo-Qing
    Zhao, Guo-Ping
    Wu, Yi-Long
    Zhong, Wen-Zhao
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (04) : 509 - +
  • [12] Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma
    Zhou, Shuyi
    Cai, Yuan
    Xu, Zhijie
    Peng, Bi
    Liang, Qiuju
    Peng, Jinwu
    Yan, Yuanliang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [13] Identification of a 5-lncRNA signature-based risk scoring system for survival prediction in colorectal cancer
    Gu, Liqiang
    Yu, Jun
    Wang, Qing
    Xu, Bin
    Ji, Liechen
    Yu, Lin
    Zhang, Xipeng
    Cai, Hui
    MOLECULAR MEDICINE REPORTS, 2018, 18 (01) : 279 - 291
  • [14] Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
    Wu, Guomin
    Wang, Qihao
    Zhu, Ting
    Fu, Linhai
    Li, Zhupeng
    Wu, Yuanlin
    Zhang, Chu
    FRONTIERS IN GENETICS, 2021, 12
  • [15] High-risk early-stage lung adenocarcinoma patients are identified by an immune-related circadian clock gene signature
    Wang, Zi-Hao
    Zhang, Pei
    Du, Yi-Heng
    Wei, Xiao-Shan
    Ye, Lin-Lin
    Niu, Yi-Ran
    Xiang, Xuan
    Peng, Wen-Bei
    Su, Yuan
    Zhou, Qiang
    JOURNAL OF THORACIC DISEASE, 2022, : 3748 - 3761
  • [16] Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma
    Yi, Lilan
    Huang, Ping
    Gu, Yinfang
    Wu, Guowu
    Zou, Xiaofang
    Guo, Longhua
    Wen, Chunling
    Zhu, Junlin
    Zhao, Dongdong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [17] Delineate methylation landscape of circulating T cells as a diagnostic signature for early-stage lung adenocarcinoma
    Wang, Yu-Ching
    Huang, Yi-Jhen
    Lin, Shu-Yung
    Su, Sheng-Yao
    Yu, Chong-Jen
    Tsai, Hsing-Chen
    RESPIROLOGY, 2024, 29 : 36 - 36
  • [18] Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma
    Lu, Lu
    Liu, Le-Ping
    Zhao, Qiang-Qiang
    Gui, Rong
    Zhao, Qin-Yu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [19] Radiomics Signature to Predict Prognosis in Early-Stage Lung Adenocarcinoma (≤3 cm) Patients with No Lymph Node Metastasis
    Zhang, Li
    Lv, Lv
    Li, Lin
    Wang, Yan-Mei
    Zhao, Shuang
    Miao, Lei
    Gao, Yan-Ning
    Li, Meng
    Wu, Ning
    DIAGNOSTICS, 2022, 12 (08)
  • [20] A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma
    Wang, Xinyi
    Jing, Hui
    Li, Hecheng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (02) : 230 - +
12345